JANINE RUTHERFORD: Open Payments
NPI 1831580018 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$202 in 9 payments from 7 companies in 2025. Trend: 2023 $13 · 2024 $0 · 2025 $202
Food & beverage: $202
| Company | Payments | Amount |
|---|---|---|
| Neurelis, Inc. | 2 | $77 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $22 |
| Biogen, Inc. | 1 | $21 |
| SCILEX PHARMACEUTICALS INC. | 1 | $15 |
| Solventum Corporation | 1 | $14 |
| Kerecis Limited | 1 | $10 |
Products named: VALTOCO, KESIMPTA, JOURNAVX, VUMERITY, ELYXYB - CELECOXIB, ACTIV.A.C., Kerecis SurgiClose.
Industry payments across AR — which companies pay providers there.
